Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin

被引:149
作者
Dagan, R
Abramson, O
Leibovitz, E
Lang, R
Goshen, S
Greenberg, D
Yagupsky, P
Leiberman, A
Fliss, DM
机构
[1] SOROKA UNIV, MED CTR, CLIN MICROBIOL LAB, IL-84101 BEER SHEVA, ISRAEL
[2] SOROKA UNIV, MED CTR, DEPT OTOLARYNGOL, IL-84101 BEER SHEVA, ISRAEL
[3] BEN GURION UNIV NEGEV, FAC HLTH SCI, BEER SHEVA, ISRAEL
[4] MEIR MED CTR, DEPT OTOLARYNGOL, TEL AVIV, ISRAEL
[5] TEL AVIV UNIV, IL-69978 TEL AVIV, ISRAEL
[6] MEIR MED CTR, INFECT DIS UNIT, TEL AVIV, ISRAEL
关键词
otitis media; Streptococcus pneumoniae; antibiotic resistance; cephalosporins;
D O I
10.1097/00006454-199611000-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Penicillin resistance of Streptococcus pneumoniae, one of the most common causes of acute otitis media, has recently increased and is now highly prevalent in many regions. However, its contribution to clinical failure still must be proved, Because the role of antibiotics in acute otitis media is to eradicate the pathogens present in the middle ear fluid, we conducted a randomized controlled study to determine bacterial eradication of pathogens in acute otitis media by two commonly used oral cephalosporins, cefuroxime axetil (30 mg/kg/day) and cefaclor (40 mg/kg/day). Methods. Patients 6 to 36 months old with pneumococcal otitis media seen in the Pediatrics Emergency Room were studied, An initial middle ear fluid culture was obtained at enrollment, and a second culture was obtained on Day 4 or 5 during treatment. Follow-up was done also on Days 10, 17 and 42 after initiation of treatment, In cases of clinical relapse a third culture was obtained. Results. In total 78 patients were enrolled, 41 in the cefuroxime axetil group and 37 in the cefaclor group, Of the 78 S. pneumoniae isolates 31 (40%) were intermediately penicillin-resistant (MIC 0.125 to 1.0 mu g/ml). Of the 47 patients with penicillin-susceptible organisms 3 (6%) had bacteriologic failure vs, 4 of 19 (21%) and 7 of 11 (64%) of those with MIC of 0.125 to 0.25 mu g/ml and 0.38 to 1.0 mu g/ml, respectively (P < 0.001). For intermediately resistant pneumococci, in 7 of 12 (58%) of those receiving cefaclor the isolate was not eradicated vs. only 4 of 19 (21%) of those receiving cefuroxime axetil (P = 0.084), MIC to the administered cephalosporin of >0.5 mu g/ml was associated with bacteriologic failure. Clinical failure was observed in 9 of 14 (64%) patients with bacteriologic failure vs. 10 of 52 (19%) patients with bacteriologic eradication (P = 0.003). Conclusion. Intermediately penicillin-resistant S. pneumoniae is associated with an impaired bacteriologic and clinical response of acute otitis media to cefaclor and cefuroxime axetil. This effect was more pronounced with cefaclor than with cefuroxime axetil.
引用
收藏
页码:980 / 985
页数:6
相关论文
共 37 条
  • [1] ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW
    APPELBAUM, PC
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) : 77 - 83
  • [2] AUSTRIAN R, 1976, MT SINAI J MED, V43, P699
  • [3] BARNETT ED, 1995, PEDIATR CLIN N AM, V42, P509
  • [4] Barnett Elizabeth D., 1993, Pediatric Research, V33, p162A
  • [5] CLINICAL OUTCOME OF ACUTE OTITIS-MEDIA CAUSED BY PNEUMOCOCCI WITH DECREASED SUSCEPTIBILITY TO PENICILLIN
    BARRY, B
    GEHANNO, P
    BLUMEN, M
    BOUCOT, I
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1994, 26 (04) : 446 - 452
  • [6] EFFECT OF INCREASED DOSAGES OF AMOXICILLIN IN TREATMENT OF EXPERIMENTAL MIDDLE-EAR OTITIS DUE TO PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE
    BARRY, B
    MUFFATJOLY, M
    GEHANNO, P
    POCIDALO, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) : 1599 - 1603
  • [7] BERCHE P, 1994, ACTUALITES STREPTOCO, P26
  • [8] 10-YEAR REVIEW OF OTITIS-MEDIA PATHOGENS
    BLUESTONE, CD
    STEPHENSON, JS
    MARTIN, LM
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1992, 11 (08) : S7 - S11
  • [9] Centers for Disease Control and Prevention (CDC), 1994, MMWR Morb Mortal Wkly Rep, V43, P23
  • [10] COHEN R, 1995, 35 INT C ANT AG CHEM